ABEVMY

Google image searchProduct monograph

Active ingredient

bevacizumab, 100 MG/4 ML

DIN: 02522179

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINLGE-USE VIAL

Schedule: Prescription / Schedule D

Company: BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Date: 15-MAY-2023

ATC:

Reference brand drug: Avastin

Search on Google